Michael F. MacLean - Sep 11, 2023 Form 4 Insider Report for Avidity Biosciences, Inc. (RNA)

Role
Chief Financial Officer
Signature
/s/ John W. Wallen III, Ph.D., J.D., Attorney-in-Fact
Stock symbol
RNA
Transactions as of
Sep 11, 2023
Transactions value $
$0
Form type
4
Date filed
9/12/2023, 07:33 PM
Previous filing
Jun 20, 2023
Next filing
Jan 23, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RNA Stock Option (Right to Buy) Award $0 +74K $0.00 74K Sep 11, 2023 Common Stock 74K $6.57 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48th of the total number of shares subject to the options shall vest on each monthly anniversary of September 11, 2023 (the "Vesting Commencement Date"), subject to the Reporting Person's continuous service to the Issuer on each such vesting date, so that the options shall be fully vested on the fourth anniversary of the Vesting Commencement Date.